Global cell harvesting system market was worth USD 3.17 billion in 2016. It is forecast to grow at a CAGR 13.9% during the forecast period. The industry's growth is driven by rising demand for stem-cell-based therapy and increased investment in clinical research due to its potential benefits in regenerative medicines.
Stem cell-based therapy will continue to grow in demand due to an aging population and the rising prevalence of chronic diseases such as heart disease. Stem cell-based research has seen a dramatic increase in the last decade. This is driving demand for stem cell harvesting to be used for research. The National Institutes of Health (NIH), the primary U.S. agency for biomedical research and public health, spent USD 1.49 billion on stem cell research in 2016. This was approximately 5.0% more than 2015.
Stem cell banking is also on the rise due to the increasing transplantation rate. Research into stem cell sources such as embryonic stem cells and umbilical cord stem cells is driving the development of regenerative products and treatment of cancer.
The market's growth will be limited by ethical concerns regarding embryonic stem cells as well as unapproved stem cell therapy offered by healthcare providers in unregulated areas such Latin America and Asia Pacific.
This technique can be used to extract stem cells from the umbilical cord and bone marrow, peripheral, adipose, and other sources. In 2016, the market share for peripheral blood was the largest and it is expected to continue its dominance over the forecast period. This is due to the increasing use of peripheral plasma in stem cell transplants, and the increased use of peripheral plasma in stem cell research.
Due to liposuction's ability to retrieve more stem cells and the potential use of these stem cells in regenerative medicine, adipose tissue will experience the fastest growth. The lucrative growth of the umbilical cord will also be due to its potential use in other therapies and increasing use in transplantation.
The market can be divided into four segments based on end-use: hospitals, clinics and academic institutes. The largest share was held by hospitals and will continue to dominate the market over the forecast period. This is because the majority of stem cell transplantation & research takes place in hospitals.
Due to increased investment by universities and biopharmaceutical firms in research, academic institutes and R&D centres are expected to experience the greatest growth. Research in academic institutes will continue to grow due to the rising demand for stem cell-based therapies and regenerative medicine.
North America and Europe accounted for over 74% of the total revenue, while Europe dominated the market in 2016. It is home to most stem cell transplants, which accounts for a large portion of the market share in cell harvesting systems.
North America was the dominant research region in 2016, with more than 54.0% stem cell clinical trials conducted in this area. This region is also home to the second largest number of stem cell transplantation. This further drives the demand for harvesting.
Asia Pacific is expected to experience a significant growth in the future, due to rising rates of chronic diseases and increased demand for stem cell transplantation. Japan and China are Asia Pacific's largest markets for harvesting technology. Over the forecast period, emerging countries like South Korea, South Africa, and Mexico are expected to experience lucrative growth. These countries have a growing demand for stem cell therapies. This can be explained by the increased investment made by governments in stem cell-based research.
Argos Technologies, Inc., Perkin Elmer, Inc., Brand GmBh + CO KG, Arthrex, Inc., Avita Medical, Tomtec, Terumo Corporation, Teleflex, Inc., and Bertin are the primary market participants.
Terumo Corporation offers a variety of products, including harvesters and apheresis system. Terumo BCT established a strategic partnership with Cognate Bioservices, a bioservice contract company, in September 2016 to develop immunotherapy products and increase the use of quantum systems in cell therapy manufacturing.
This report predicts revenue growth at the global, regional and country levels. It also analyzes the industry trends for each sub-segment from 2014 through 2025. Up Market Research has divided the global cell harvesting market by application, end-use, and geography.
App Outlook (Revenue USD Million, 2014-2025)
Umbilical Cord
Bone Marrow
Peripheral blood
Adipose tissue
Sources other than Wikipedia
End-use Outlook (Revenue USD Million, 2014-2025)
Hospitals
Clinics
Academic institutions
R&D centres
Regional Outlook (Revenue USD Million, 2014-2025)
North America
The U.S.
Canada
Europe
Germany
The U.K.
Asia Pacific
China
Japan
Latin America
Brazil
Mexico
MEA
South Africa
Saudi Arabia
b. Global cell harvesting market was valued at USD 4.6 billion in 2019, and is forecast to grow to USD 5.3 billion by 2020.
What is the market growth for cell harvesting systems?b. Global cell harvesting market is expected to grow at a compound annual rate of 13.9% between 2017 and 2025, reaching USD 10.2 billion in 2025.
Which market segment had the largest share of cell harvesting systems?b. With a 35.1% share in 2019, North America was the dominant market for cell harvesting systems. This can be attributed to the increase in stem cell clinical trials and stem cell transplantation.
What are the major players in the cell harvesting market?b. Argos Technologies, Inc., Perkin Elmer, Inc., Brand GmBh + CO KG, Arthrex, Inc., Avita Medical, Tomtec, Terumo Corporation, Teleflex, Inc., and Bertin are some of the key players in the cell harvesting market.
What are the market forces for cell harvesting systems?b. Market growth is being driven by a rise stem cell transplantation, increased stem cell research, as well as a rising demand for stem cells therapy.
Up Market Research published a new report titled “Cell Harvesting System Market research report which is segmented by End Use (Clinics, R&D Centers, Hospitals), by Application (Umbilical Cord, Peripheral Blood, Adipose Tissue, Bone marrow), By Players/Companies Inc; Avita Medical; Tomtec; Terumo Corporation; Teleflex, Inc; Perkin Elmer, Argos Technologies, Inc; Brand GmBh + CO KG; Arthrex, Inc; and Bertin”. As per the study the market is expected to grow at a CAGR of XX% in the forecast period.
Report Attributes | Report Details |
Report Title | Cell Harvesting System Market Research Report |
By End Use | Clinics, R&D Centers, Hospitals |
By Application | Umbilical Cord, Peripheral Blood, Adipose Tissue, Bone marrow |
By Companies | Inc; Avita Medical; Tomtec; Terumo Corporation; Teleflex, Inc; Perkin Elmer, Argos Technologies, Inc; Brand GmBh + CO KG; Arthrex, Inc; and Bertin |
Regions Covered | North America, Europe, APAC, Latin America, MEA |
Base Year | 2020 |
Historical Year | 2018 to 2019 (Data from 2010 can be provided as per availability) |
Forecast Year | 2028 |
Number of Pages | 229 |
Number of Tables & Figures | 161 |
Customization Available | Yes, the report can be customized as per your need. |
The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.
The market is segmented by End Use (Clinics, R&D Centers, Hospitals), by Application (Umbilical Cord, Peripheral Blood, Adipose Tissue, Bone marrow).
Cell Harvesting System Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.
Key Benefits for Industry Participants & Stakeholders:
Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.
We have studied the Cell Harvesting System Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.
How you may use our products:
Reasons to Purchase the Cell Harvesting System Market Report:
Some other reports from this category!